<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Ophthalmol</journal-id>
      <journal-title-group>
        <journal-title>BMC Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24989140</article-id>
      <article-id pub-id-type="pmc">4090392</article-id>
      <article-id pub-id-type="publisher-id">1471-2415-14-88</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2415-14-88</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Deferoxamine retinopathy: spectral domain-optical coherence tomography findings</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Wu</surname>
            <given-names>Cheng-Hsiu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>samuxgm@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Yang</surname>
            <given-names>Chao-Ping</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>ilvlct@cgmh.org.tw</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Lai</surname>
            <given-names>Chi-Chun</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>chichun.lai@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Wu</surname>
            <given-names>Wei-Chi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>weichi666@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A5">
          <name>
            <surname>Chen</surname>
            <given-names>Yi-Hsing</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>yihsing@gmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Ophthalmology, Chang Gung Memorial Hospital, No. 5, Fu-Hsing Street, Kweishan, Taoyuan 333, Taiwan</aff>
      <aff id="I2"><label>2</label>Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan</aff>
      <aff id="I3"><label>3</label>College of Medicine, Chang Gung University, Taoyuan, Taiwan</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>14</volume>
      <fpage>88</fpage>
      <lpage>88</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>6</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 Wu et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Wu et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2415/14/88"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>To describe the spectral domain optical coherence tomography (SD-OCT) findings of a patient who developed pigmentary retinopathy following high-dose deferoxamine administration.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 34-year-old man with thalassemia major complained of nyctalopia and decreased vision following high-dose intravenous deferoxamine to treat systemic iron overload. Fundus examination revealed multiple discrete hypo-pigmented lesions at the posterior pole and mid-peripheral retina. Recovery was partial following cessation of desferrioxamine six weeks later. A follow-up SD-OCT showed multiple accumulated hyper-reflective deposits primarily in the choroid, retina pigment epithelium (RPE), and inner segment and outer segment (IS/OS) junction.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Deferoxamine retinopathy primarily targets the RPE&#x2013;Bruch membrane&#x2013;photoreceptor complex, extending from the peri-fovea to the peripheral retina with foveola sparing. An SD-OCT examination can serve as a simple, noninvasive tool for early detection and long-term follow-up.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Spectral domain optical coherence tomography</kwd>
        <kwd>Deferoxamine</kwd>
        <kwd>Retinopathy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Deferoxamine is an iron-chelating agent used to treat chronic iron overload in patients with thalassemia major and other hematologic conditions requiring routine blood transfusion [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The incidence of deferoxamine-related ocular toxicity is approximately 1.2% based on a prior study [<xref ref-type="bibr" rid="B3">3</xref>]. The clinical presentations may include night blindness, centrocaecal scotoma, constricted peripheral visual field, pigmentary retinopathy, and optic neuropathy [<xref ref-type="bibr" rid="B3">3</xref>]. Retinal pigmentary change was most frequently reported [<xref ref-type="bibr" rid="B4">4</xref>]. This case report pathologically characterizes the spectral domain optical coherence tomography (SD-OCT, SPECTRALIS SD-OCT, Heidelberg, Germany) and near-infrared reflectance (NIR) findings in a patient with deferoxamine retinopathy.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 34-year-old Taiwanese man with beta-thalassemia major had been administered routine blood transfusion and subcutaneous deferoxamine at 30&#xA0;mg/kg/day for 20&#xA0;years since youth. He was hospitalized for a compression fracture and myelopathy of the thoracic spine. He presented with acute onset of decreased vision, impaired color vision, and night blindness following continuous intravenous deferoxamine (98&#xA0;mg/kg) for 42&#xA0;days for the treatment of elevated serum ferritin level. On ophthalmic examinations, the best-corrected vision was 20/200 in the right eye and 20/40 in the left eye. The intraocular pressure measurement and anterior segment examination yielded normal results for both eyes. The fundus examination revealed multiple discrete hypo-pigmented circular lesions over the posterior pole and mid-peripheral retina in both eyes.Deferoxamine retinopathy was suspected, and the patient was switched to oral deferasirox/deferiprone. Six weeks later, there was an improvement in the best-corrected vision (20/60 in the right eye and 20/25 in the left eye) and color vision. Retinal pigmentary changes became confluent (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). NIR showed hyper-reflective deposits particularly in the parafoveal and perifoveal areas (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>). SD-OCT showed multiple confluent hyper-reflective deposits in the choroid, retinal pigment epithelium (RPE) and IS/OS junction. Thickened RPE, Bruch&#x2019;s membrane, and choroid space were also discovered. The IS/OS junction was most severely disrupted at the perifoveal and parafoveal areas than at the foveola area (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Dilated fundus examination at the 6-week follow-up visit.</bold> A dilated fundus examination revealed diffuse and confluent hypo-pigmented pinpoint lesions extending from the posterior pole (arrow) to the peripheral retina (arrowhead).</p>
        </caption>
        <graphic xlink:href="1471-2415-14-88-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Near-infrared reflectance (NIR) at the 6-week re-examination.</bold> NIR showed hyper-reflective deposits particularly in the parafoveal and perifoveal areas.</p>
        </caption>
        <graphic xlink:href="1471-2415-14-88-2"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p><bold>SD-OCT at the 6-week re-examination.</bold> SD-OCT revealed a disrupted IS/OS junction (arrow) and multiple diffuse and confluent hyper-reflective deposits in the retinal pigment epithelium (RPE), IS/OS junction, and choroid (arrowhead). Thickened RPE, Bruch&#x2019;s membrane, and choroidal space were also observed.</p>
        </caption>
        <graphic xlink:href="1471-2415-14-88-3"/>
      </fig>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>Deferoxamine is a widely used chelating agent in treating transfusional hemochromatosis [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Visual symptoms included decreased visual acuity, night blindness, and colour vision abnormalities [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. These ophthalmic examination findings have been reported extensively. Sumu et al. observed speckled hyper-fluorescence with well-demarcated areas of blocked fluorescence on fluorescein angiography [<xref ref-type="bibr" rid="B6">6</xref>]. Markedly reduced photopic, scotopic, and 30-Hz flicker response amplitudes were reported on electroretinograms. Electro-oculogram typically showed reduced light-peak to dark-trough ratios [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Viola et al. reported abnormal fundus autofluorescence in 9% of 197 patients, but only 5 patients reported visual symptoms [<xref ref-type="bibr" rid="B7">7</xref>]. Viola et al. further described the pattern dystrophy&#x2013;like or minimal changes of macular lesions in patients with deferoxamine retinopathy by using NIR and SD-OCT which pointed out the disease itself affects the RPE&#x2013;Bruch membrane&#x2013;photoreceptor complex [<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>The pathophysiology of deferoxamine-related retinopathy has been investigated for several years. Rahi et al. first reported electron microscopic findings of deferoxamine retinopathy, including patchy RPE depigmentation, abnormally thickened Bruch's membrane, and normal photoreceptors [<xref ref-type="bibr" rid="B9">9</xref>]. Previous studies also discovered that iron overload and iron-chelating agents both may be mutually confounding factors in the causation of ocular changes of thalassemia such as RPE mottling [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. The SD-OCT findings in our case revealed multiple confluent hyper-reflective deposits in the RPE, IS/OS junction and choroid (Figure&#xA0;<xref ref-type="fig" rid="F3">3</xref>). We hypothesized that hyper-reflective deposits detected by means of SD-OCT may represent a primarily involvement of RPE&#x2013;Bruch membrane&#x2013;photoreceptor complex in deferoxamine toxicity which correlated with previous histologic findings [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>Ocular deferoxamine toxicity could cause vision impairment; regular ophthalmic assessment is required in these patients. We presented the SD-OCT findings of deferoxamine retinopathy highly correlated with previous histologic descriptions and showed that the toxicity primarily involved the RPE&#x2013;Bruch membrane&#x2013;photoreceptor complex. Noninvasive SD-OCT and NIR imaging, both well tolerated by patients, may be helpful in early detection and long-term monitoring.</p>
      <sec>
        <title>Consent</title>
        <p>The patient provided written informed consent for the publication of this case report and any accompanying images. A copy of the written consent is available for editorial review.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>SD-OCT: Spectral domain optical coherence tomography; IS/OS: Inner segment/outer segment; RPE: Retinal pigment epithelium.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>C-HW conducted the literature search and composed the manuscript. Y-HC conceived the idea for the manuscript, conducted a literature search, and critiqued the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2415/14/88/prepub">http://www.biomedcentral.com/1471-2415/14/88/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>The authors thank Dr. Chao-Ping Yang from the Department of Pediatrics, Chang Gung Memorial Hospital, in Taoyuan, Taiwan for her expertise in managing this patient.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kontoghiorghes</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Pattichi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hadjigavriel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kolnagou</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)</article-title>
          <source>Transfus Sci</source>
          <year>2000</year>
          <volume>23</volume>
          <issue>3</issue>
          <fpage>211</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="pmid">11099897</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lakhanpal</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Schocket</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Jiji</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy</article-title>
          <source>Ophthalmol</source>
          <year>1984</year>
          <volume>91</volume>
          <issue>5</issue>
          <fpage>443</fpage>
          <lpage>451</lpage>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Baath</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Lam</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Kirby</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chun</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population</article-title>
          <source>Retina</source>
          <year>2008</year>
          <volume>28</volume>
          <issue>6</issue>
          <fpage>894</fpage>
          <lpage>899</lpage>
          <pub-id pub-id-type="pmid">18536609</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Haimovici</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>D'Amico</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Gragoudas</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Sokol</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Deferoxamine Retinopathy Study G: The expanded clinical spectrum of deferoxamine retinopathy</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>109</volume>
          <issue>1</issue>
          <fpage>164</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">11772599</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Arora</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wren</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gregory Evans</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Desferrioxamine related maculopathy: a case report</article-title>
          <source>Am J Hematol</source>
          <year>2004</year>
          <volume>76</volume>
          <issue>4</issue>
          <fpage>386</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">15282675</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Simon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Athanasiov</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gilhotra</surname>
            <given-names>JS</given-names>
          </name>
          <article-title>Desferrioxamine-related ocular toxicity: a case report</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2012</year>
          <volume>60</volume>
          <issue>4</issue>
          <fpage>315</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">22824603</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Viola</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Barteselli</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dell'arti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vezzola</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Villani</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mapelli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zanaboni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cappellini</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Ratiglia</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine</article-title>
          <source>Ophthalmol</source>
          <year>2012</year>
          <volume>119</volume>
          <issue>8</issue>
          <fpage>1693</fpage>
          <lpage>1700</lpage>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Viola</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Barteselli</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dell'arti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vezzola</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mapelli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Villani</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ratiglia</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Multimodal Imaging in Deferoxamine Retinopathy</article-title>
          <source>Retina</source>
          <year>2013</year>
          <volume>0</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rahi</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Hungerford</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Ahmed</surname>
            <given-names>AI</given-names>
          </name>
          <article-title>Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings</article-title>
          <source>Br J Ophthalmol</source>
          <year>1986</year>
          <volume>70</volume>
          <issue>5</issue>
          <fpage>373</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="pmid">3964637</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Taneja</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Malik</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Agarwal</surname>
            <given-names>MC</given-names>
          </name>
          <article-title>Multiple transfused thalassemia major: ocular manifestations in a hospital-based population</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2010</year>
          <volume>58</volume>
          <issue>2</issue>
          <fpage>125</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">20195035</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Blake</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Winyard</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lunec</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Good</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Crewes</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Gutteridge</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Rowley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Halliwell</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cornish</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hider</surname>
            <given-names>RC</given-names>
          </name>
          <article-title>Cerebral and ocular toxicity induced by desferrioxamine</article-title>
          <source>Q J Med</source>
          <year>1985</year>
          <volume>56</volume>
          <issue>219</issue>
          <fpage>345</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">4095247</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Virgiliis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Congia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Turco</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Frau</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dessi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Argiolu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sorcinelli</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sitzia</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia</article-title>
          <source>Arch Dis Child</source>
          <year>1988</year>
          <volume>63</volume>
          <issue>3</issue>
          <fpage>250</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">3355204</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Davies</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Marcus</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Hungerford</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Arden</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Huehns</surname>
            <given-names>ER</given-names>
          </name>
          <article-title>Ocular toxicity of high-dose intravenous desferrioxamine</article-title>
          <source>Lancet</source>
          <year>1983</year>
          <volume>2</volume>
          <issue>8343</issue>
          <fpage>181</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">6135026</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
